Bio-reference Labs (BRLI) Tops Q3 EPS by 2c

August 30, 2012 8:37 AM EDT
Bio-reference Labs (NASDAQ: BRLI) reported Q3 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $172.3 thousand versus the consensus estimate of $173.7 thousand.

The Estimize consensus was $0.43 and $175.03 million, respectively.

For earnings history and earnings-related data on Bio-reference Labs (BRLI) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings